| Deep Track Capital, LP |
Delaware |
0 |
3254132 |
0 |
0 |
3254132 |
5.21 % |
14/04/2023 |
| Deep Track Biotechnology Master Fund, Ltd. |
Delaware |
0 |
3254132 |
0 |
0 |
3254132 |
5.21 % |
14/04/2023 |
| David Kroin |
Delaware |
0 |
3254132 |
0 |
0 |
3254132 |
5.21 % |
14/04/2023 |
| STATE STREET CORPORATION |
BOSTON, MASSACHUSETTS |
0 |
3697668 |
0 |
3755689 |
3755689 |
6.02 % |
10/02/2023 |
| (1) BlackRock, Inc. |
Delaware |
3234937 |
0 |
3324738 |
0 |
3324738 |
5.3 % |
07/02/2023 |
| 10 |
Delaware |
0 |
0 |
3421541 |
3421541 |
3421541 |
5.7 % |
19/09/2022 |
| 5.7%* |
Delaware |
0 |
0 |
3421541 |
3421541 |
3421541 |
5.7 % |
19/09/2022 |
| 10 |
Delaware |
0 |
0 |
3421541 |
3421541 |
3421541 |
5.7 % |
19/09/2022 |
| EcoR1 Capital Fund Qualified, L.P. |
Delaware |
0 |
0 |
0 |
3261797 |
3261797 |
11 % |
19/09/2022 |
| Oleg Nodelman |
Delaware |
0 |
0 |
0 |
0 |
3460208 |
11 % |
19/09/2022 |
| EcoR1 Capital, LLC |
Delaware |
0 |
0 |
0 |
0 |
3460208 |
11 % |
19/09/2022 |
| OrbiMed Capital GP VI LLC |
Delaware |
0 |
5599842 |
0 |
10 |
5599842 |
9.3 % |
14/09/2022 |
| OrbiMed Advisors LLC |
Delaware |
0 |
5599842 |
0 |
10 |
5599842 |
9.3 % |
14/09/2022 |
| Perceptive Life Sciences Master Fund, Ltd. |
Delaware |
0 |
4849912 |
0 |
4849912 |
4849912 |
9.8 % |
14/02/2022 |
| Perceptive Advisors LLC |
Delaware |
0 |
4849912 |
0 |
4849912 |
4849912 |
9.8 % |
14/02/2022 |
| Joseph Edelman |
Delaware |
0 |
4849912 |
0 |
4849912 |
4849912 |
9.8 % |
14/02/2022 |
| (VOLUNTARY) 98-1625134 |
Netherlands |
0 |
2328548 |
0 |
0 |
2328548 |
4.73 % |
11/02/2022 |
| Pfizer Inc. 13-5315170 |
Delaware |
11782 |
2328548 |
11782 |
0 |
2340330 |
4.75 % |
11/02/2022 |
| The Vanguard Group - 23-1945930 |
|
0 |
0 |
0 |
73860 |
2862312 |
5.81 % |
10/02/2022 |
| FMR LLC |
Delaware |
1616332 |
0 |
3946320 |
0 |
3946320 |
8.012 % |
09/02/2022 |
| Abigail P. Johnson |
United States of America |
0 |
0 |
3946320 |
0 |
3946320 |
8.012 % |
09/02/2022 |
| BC SW, LP |
|
0 |
4831307 |
0 |
4831307 |
4831307 |
9.8 % |
12/08/2021 |
| BC SW, LP |
|
0 |
5831307 |
0 |
5831307 |
5831307 |
11.9 % |
11/03/2021 |
| OrbiMed Capital GP VI LLC |
Delaware |
0 |
6186307 |
0 |
10 |
6186307 |
12.6 % |
03/03/2021 |
| OrbiMed Advisors LLC |
Delaware |
0 |
6186307 |
0 |
10 |
6186307 |
12.6 % |
03/03/2021 |
| Perceptive Life Sciences Master Fund, Ltd. |
|
0 |
4177721 |
0 |
4177721 |
4177721 |
8.6 % |
16/02/2021 |
| Joseph Edelman |
|
0 |
4177721 |
0 |
4177721 |
4177721 |
8.6 % |
16/02/2021 |
| Perceptive Advisors LLC |
|
0 |
4177721 |
0 |
4177721 |
4177721 |
8.6 % |
16/02/2021 |
| Pfizer Ventures (US) LLC |
Delaware |
0 |
576602 |
0 |
0 |
576602 |
1.2 % |
12/02/2021 |
| Pfizer Inc. |
Delaware |
4006445 |
576602 |
4006445 |
0 |
4583047 |
9.4 % |
12/02/2021 |
| BC SW, LP |
|
0 |
7281307 |
0 |
7281307 |
7281307 |
15 % |
15/10/2020 |
| OrbiMed Capital GP VI LLC |
Delaware |
0 |
7406307 |
0 |
10 |
7406307 |
15.5 % |
13/10/2020 |
| OrbiMed Advisors LLC |
Delaware |
0 |
7406307 |
0 |
10 |
7406307 |
15.5 % |
13/10/2020 |
| Joseph Edelman |
Delaware |
0 |
3297522 |
0 |
3297522 |
3297522 |
7.7 % |
14/02/2020 |
| Perceptive Life Sciences Master Fund, Ltd. |
Delaware |
0 |
3297522 |
0 |
3297522 |
3297522 |
7.7 % |
14/02/2020 |
| Perceptive Advisors LLC |
Delaware |
0 |
3297522 |
0 |
3297522 |
3297522 |
7.7 % |
14/02/2020 |
| BVF I GP LLC |
|
0 |
0 |
0 |
1523711 |
1523711 |
3.5 % |
14/02/2020 |
| Biotechnology Value Fund, L.P. |
|
0 |
0 |
0 |
1523711 |
1523711 |
3.5 % |
14/02/2020 |
| Biotechnology Value Fund II, L.P. |
|
0 |
0 |
0 |
1216773 |
1216773 |
2.8 % |
14/02/2020 |
| BVF II GP LLC |
|
0 |
0 |
0 |
1216773 |
1216773 |
2.8 % |
14/02/2020 |
| Biotechnology Value Trading Fund OS LP |
|
0 |
0 |
0 |
213125 |
213125 |
1 % |
14/02/2020 |
| BVF Partners OS Ltd. |
|
0 |
0 |
0 |
213125 |
213125 |
1 % |
14/02/2020 |
| BVF GP HOLDINGS LLC |
|
0 |
0 |
0 |
2740484 |
2740484 |
6.4 % |
14/02/2020 |
| BVF Partners L.P. |
|
0 |
0 |
0 |
3079155 |
3079155 |
7.2 % |
14/02/2020 |
| BVF Inc. |
|
0 |
0 |
0 |
3079155 |
3079155 |
7.2 % |
14/02/2020 |
| Mark N. Lampert |
|
0 |
0 |
0 |
3079155 |
3079155 |
7.2 % |
14/02/2020 |
| Pfizer Ventures (US) LLC |
Delaware |
0 |
576602 |
0 |
0 |
576602 |
1.3 % |
14/02/2020 |
| Pfizer Inc. |
Delaware |
4017245 |
576602 |
4017245 |
0 |
4593847 |
10.7 % |
14/02/2020 |
| Perceptive Life Sciences Master Fund, Ltd. |
Delaware |
0 |
3217522 |
0 |
3217522 |
3217522 |
7.4 % |
26/09/2019 |
| Perceptive Advisors LLC |
Delaware |
0 |
3217522 |
0 |
3217522 |
3217522 |
7.4 % |
26/09/2019 |
| Joseph Edelman |
Delaware |
0 |
3217522 |
0 |
3217522 |
3217522 |
7.4 % |
26/09/2019 |
| OrbiMed Capital GP VI LLC |
Delaware |
0 |
7406307 |
0 |
10 |
7406307 |
17.1 % |
25/09/2019 |
| OrbiMed Advisors LLC |
Delaware |
0 |
7406307 |
0 |
10 |
7406307 |
17.1 % |
25/09/2019 |
| Mark N. Lampert |
Delaware |
0 |
0 |
0 |
2843845 |
2843845 |
6.6 % |
23/09/2019 |
| Biotechnology Value Trading Fund OS LP |
Delaware |
0 |
0 |
0 |
201161 |
201161 |
1 % |
23/09/2019 |
| Biotechnology Value Fund II, L.P. |
Delaware |
0 |
0 |
0 |
1136339 |
1136339 |
2.6 % |
23/09/2019 |
| Biotechnology Value Fund, L.P. |
Delaware |
0 |
0 |
0 |
1386779 |
1386779 |
3.2 % |
23/09/2019 |
| BVF Inc. |
Delaware |
0 |
0 |
0 |
2843845 |
2843845 |
6.6 % |
23/09/2019 |
| BVF Partners L.P. |
Delaware |
0 |
0 |
0 |
2843845 |
2843845 |
6.6 % |
23/09/2019 |
| BVF Partners OS Ltd. |
Delaware |
0 |
0 |
0 |
201161 |
201161 |
1 % |
23/09/2019 |